ProCE Banner Activity

Key Viral Hepatitis Studies Influencing My Practice Following EASL 2022—Prof Tarik Asselah

Conference Coverage
Multimedia

Listen to expert insights on updates and new viral hepatitis data from EASL 2022, including data on investigational HBV agents, progress toward HBV cure, emerging treatments for HDV, HCV treatment implementation in treatment-experienced patients, and more.

Released: July 08, 2022

Expiration: July 07, 2023

No longer available for credit.

Share

Faculty

Tarik Asselah

Tarik Asselah, MD, PhD

Professor of Medicine
Department of Hepatology
Hôpital Beaujon
Université de Paris-Cité & INSERM 
Clichy, France

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by educational grants from

AbbVie

Gilead Sciences, Inc.

Faculty Disclosure

Primary Author

Tarik Asselah, MD, PhD

Professor of Medicine
Department of Hepatology
Hôpital Beaujon
Université de Paris-Cité & INSERM 
Clichy, France

Tarik Asselah, MD, PhD: consulting fees: AbbVie, Eiger, Gilead Sciences, Janssen, MYR, Roche.